Clinical Trial Update: A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia [NA]

View source ↗

Summary

The document reports a completed clinical trial examining the effects of sarcosine on symptoms and brain glycine levels in individuals with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | NA | Status: COMPLETED